EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Reprogrammed MDSCs promote Th1‐dominant antitumour response via CD40 induced by autocrine TNF‐α after combining cryo‐thermal therapy with IL6 and IL17A neutralization

Yuankai Hao, Shicheng Wang iD, Junjun Wang, Zelu Zhang, Yichen Yao, Ke Wang, Ping Liu iD, Lisa X Xu

Clinical and Translational Medicine · 2025

DOI: 10.1002/ctm2.70493 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Translational Medicine, 2025. Verfasst von Yuankai Hao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Med-X Research Institute, School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, China. Hauptthemen laut MEDLINE: Tumor Necrosis Factor-alpha, Interleukin-6, Myeloid-Derived Suppressor Cells, Th1 Cells. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of China, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Mounting evidence shows that myeloid‐derived suppressor cells (MDSCs) reprogramming can significantly enhance the outcomes of immunotherapy. However, the therapeutic potential of targeting MDSCs alone is limited by persistent immunosuppressive cytokines and cellular crosstalk. In our previous study, we found that novel cryo‐thermal therapy (CTT) can drive MDSCs maturation and induce CD4 + T helper type (Th)1‐dominant differentiation, improving long‐term survival in spontaneous high metastatic mouse models. Considering the established roles of Interleukin (IL)‐6 and IL‐17A in non‐small cell lung cancer (NSCLC) progression and immune evasion, we developed a combination strategy integrating cytokine neutralization with CTT (combination therapy) in LLC1 tumor‐bearing mice. Although the combination therapy successfully promoted MDSCs maturation and Th1 differentiation, the underlying mechanistic basis remained unclear.

Methods

The combination therapy was implemented in LLC1 tumor‐bearing mice. We then observed its impacts on MDSCs maturation and Th1 differentiation and explored the related mechanisms by examining various aspects including the expression of CD40, the reactive oxygen species (ROS)‐nuclear factor‐kappa B (NF‐κB) pathway, and the induction of tumor necrosis factor‐α (TNF‐α).

Results

It was observed that the combination therapy increased the expression of CD40 on MDSCs through the ROS‐NF‐κB pathway‐dependent TNF‐α induction. This TNF‐α‐mediated CD40 upregulation facilitated Th1 polarization via CD40L engagement on CD4 + T cells. Our results provided the first mechanistic evidence that autocrine TNF‐α production by reprogrammed MDSCs governs CD40 expression following combination therapy.

Conclusion

Our research elucidated the methods and mechanisms of MDSCs reprogramming and offered a promising therapeutic strategy for patients with NSCLC and other types of cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor Necrosis Factor-alphaInterleukin-6Myeloid-Derived Suppressor CellsTh1 CellsCD40 AntigensInterleukin-17Interleukin-6 InhibitorsAnimalsMiceMice, Inbred C57BL

Stichwörter der Autor:innen

CD40CD4‐positive T‐lymphocytesinterleukin‐17Ainterleukin‐6myeloid‐derived suppressor cellstumour necrosis factor‐alpha (TNF‐α)

Substanzen

Tumor Necrosis Factor-alphaInterleukin-6CD40 AntigensInterleukin-17Interleukin-6 Inhibitors

Autor:innen und Institutionen

  • Med-X Research Institute, School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, China.

ORCID-Profile: Shicheng Wang, Ping Liu

Förderung

  • National Key R&D Program of China
  • National Key Research and Development Program of China

Zitieren

APA

Hao, Y., Wang, S., Wang, J., Zhang, Z., Yao, Y., Wang, K., Liu, P., & Xu, L. X. (2025). Reprogrammed MDSCs promote Th1‐dominant antitumour response via CD40 induced by autocrine TNF‐α after combining cryo‐thermal therapy with IL6 and IL17A neutralization. Clinical and Translational Medicine. https://doi.org/10.1002/ctm2.70493

Vancouver

Hao Y, Wang S, Wang J, Zhang Z, Yao Y, Wang K, et al. Reprogrammed MDSCs promote Th1‐dominant antitumour response via CD40 induced by autocrine TNF‐α after combining cryo‐thermal therapy with IL6 and IL17A neutralization. Clinical and Translational Medicine. 2025. doi:10.1002/ctm2.70493

BibTeX
@article{Hao2025,
  author = {Hao, Yuankai and Wang, Shicheng and Wang, Junjun and Zhang, Zelu and Yao, Yichen and Wang, Ke and Liu, Ping and Xu, Lisa X},
  title = {Reprogrammed MDSCs promote Th1‐dominant antitumour response via CD40 induced by autocrine TNF‐α after combining cryo‐thermal therapy with IL6 and IL17A neutralization},
  journal = {Clinical and Translational Medicine},
  year = {2025},
  doi = {10.1002/ctm2.70493}
}
Kostenlos starten →